Effect of Phenol Addition to Laser Treatment on Epithelialization and Healing Process in Pilonidal Sinus
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Laser Treatment, Crystallized Phenol.
- Who it may be relevant to
- Registry conditions: Pilonidal Sinus Disease, Laser Therapy. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Phenol Addition to Laser Treatment on Epithelialization and Healing Process in Pilonidal Sinus: A Prospective Randomized Controlled Clinical Trial
Overview
This study compares two treatment approaches for pilonidal sinus disease: laser treatment alone versus laser treatment combined with phenol application. Pilonidal sinus is a common condition that affects young adults and can cause significant discomfort and time off work. Participants will be randomly assigned to receive either laser treatment only (Group A) or laser treatment plus phenol application (Group B). Both treatments are minimally invasive and performed under local anesthesia as day surgery procedures. The main goal is to determine if adding phenol to laser treatment speeds up the healing process (epithelialization) and improves patient outcomes. We will measure healing time, pain levels, return to daily activities, and quality of life over a 3-month follow-up period. This research may help develop more effective treatment protocols that reduce healing time and improve patient comfort for people with pilonidal sinus disease.
Detailed description
This prospective randomized controlled clinical trial investigates whether adding crystallized phenol to laser treatment improves epithelialization and healing outcomes in patients with pilonidal sinus disease. The study will be conducted at Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital.
Study Design: 130 patients meeting inclusion criteria will be randomly assigned using computer randomization to two treatment groups (65 patients each):
Group A: Laser treatment only using SiLaC (Sinus Laser Closure) technique Group B: Combined phenol application followed by laser treatment
Treatment Procedures:
Group A receives local anesthesia, pilonidal sinus area cleaning, assessment of sinus openings, and laser probe application into sinus channels.
Group B receives local anesthesia, sinus area cleaning and curettage, crystallized phenol application into sinus channels, neutralization with saline after a specified time, followed by laser treatment.
Both groups receive standard post-operative wound care instructions and same-day discharge.
Follow-up Schedule:
Preoperative assessment Postoperative visits at 2 weeks, 4 weeks, and 3 months Clinical examination for epithelialization status Pain assessment using Visual Analog Scale (VAS 0-10) Quality of life evaluation using SF-36 questionnaire
Statistical Analysis: R software will be used for statistical analysis. Student's t-test or Mann-Whitney U test for continuous variables, chi-square test for categorical variables, and paired t-test for pre/post-treatment comparisons. Statistical significance set at p\<0.05.
Primary Outcome: Time to complete epithelialization Secondary Outcomes: Postoperative pain scores, return to daily activities time, patient satisfaction, quality of life scores, and complication rates.
Interventions
- Procedure Laser Treatment
Minimally invasive laser ablation procedure performed under local anesthesia for pilonidal sinus treatment. Laser energy is delivered through a fiber optic probe inserted into the sinus tract to achieve thermal ablation of the sinus cavity. - Drug Crystallized Phenol
rystallized phenol is applied directly into the pilonidal sinus channels after cleaning and curettage. The phenol remains in contact for a specified duration before being neutralized with normal saline irrigation.
Primary outcome measures
- Time to Complete Epithelialization [Time frame: From date of surgery until complete epithelialization is achieved, assessed up to 3 months]
Secondary outcome measures (4)
- Postoperative Pain Scores [Time frame: Measured at 2 weeks, 4 weeks, and 3 months post-surgery]
- Return to Daily Activities Time [Time frame: From date of surgery until return to normal activities, assessed up to 3 months]
- Complication Rate [Time frame: From surgery through 3 months follow-up]
- Patient Satisfaction- VAS score Patient Satisfaction Patient Satisfaction [Time frame: At 3 months post-surgery]
Eligibility criteria
Inclusion criteria
- Age 18 years and older
- Primary pilonidal sinus disease
- Three or fewer pit counts
- Willing to participate in the study and signed informed consent form
- Able to attend follow-up visits
Exclusion criteria
- Age under 18 years
- More than three pit counts
- Acute abscess presentation
- Bilateral lateral extension
- Recurrent pilonidal sinus disease
- Immunocompromised patients
- Patients unable to attend follow-up visits
- Pregnancy (if applicable)
- Severe comorbidities that contraindicate surgery under local anesthesia
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital — Istanbul
Identifiers
NCT: NCT07023952 · PSL-FENOL-2025-001